Yang Zhi-Yong, Huang Yue, Ganesh Lakshmanan, Leung Kwanyee, Kong Wing-Pui, Schwartz Owen, Subbarao Kanta, Nabel Gary J
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bldg. 40, Room 4502, MSC-3005, 40 Convent Dr., Bethesda, MD 20892-3005, USA.
J Virol. 2004 Jun;78(11):5642-50. doi: 10.1128/JVI.78.11.5642-5650.2004.
The severe acute respiratory syndrome coronavirus (SARS-CoV) synthesizes several putative viral envelope proteins, including the spike (S), membrane (M), and small envelope (E) glycoproteins. Although these proteins likely are essential for viral replication, their specific roles in SARS-CoV entry have not been defined. In this report, we show that the SARS-CoV S glycoprotein mediates viral entry through pH-dependent endocytosis. Further, we define its cellular tropism and demonstrate that virus transmission occurs through cell-mediated transfer by dendritic cells. The S glycoprotein was used successfully to pseudotype replication-defective retroviral and lentiviral vectors that readily infected Vero cells as well as primary pulmonary and renal epithelial cells from human, nonhuman primate, and, to a lesser extent, feline species. The tropism of this reporter virus was similar to that of wild-type, replication-competent SARS-CoV, and binding of purified S to susceptible target cells was demonstrated by flow cytometry. Although myeloid dendritic cells were able to interact with S and to bind virus, these cells could not be infected by SARS-CoV. However, these cells were able to transfer the virus to susceptible target cells through a synapse-like structure. Both cell-mediated infection and direct infection were inhibited by anti-S antisera, indicating that strategies directed toward this gene product are likely to confer a therapeutic benefit for antiviral drugs or the development of a SARS vaccine.
严重急性呼吸综合征冠状病毒(SARS-CoV)可合成多种假定的病毒包膜蛋白,包括刺突(S)、膜(M)和小包膜(E)糖蛋白。尽管这些蛋白可能对病毒复制至关重要,但其在SARS-CoV进入过程中的具体作用尚未明确。在本报告中,我们表明SARS-CoV S糖蛋白通过pH依赖性内吞作用介导病毒进入。此外,我们确定了其细胞嗜性,并证明病毒通过树突状细胞介导的细胞间转移进行传播。S糖蛋白成功用于假型复制缺陷型逆转录病毒和慢病毒载体,这些载体可轻易感染Vero细胞以及来自人、非人灵长类动物以及程度较轻的猫科动物的原代肺和肾上皮细胞。这种报告病毒的嗜性与具有复制能力的野生型SARS-CoV相似,并且通过流式细胞术证明了纯化的S与易感靶细胞的结合。虽然髓样树突状细胞能够与S相互作用并结合病毒,但这些细胞不能被SARS-CoV感染。然而,这些细胞能够通过类似突触的结构将病毒转移至易感靶细胞。细胞介导的感染和直接感染均被抗S抗血清抑制,这表明针对该基因产物的策略可能为抗病毒药物或SARS疫苗的开发带来治疗益处。